Search

Your search keyword '"Robert P Byington"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Robert P Byington" Remove constraint Author: "Robert P Byington"
78 results on '"Robert P Byington"'

Search Results

1. Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes

2. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

3. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

5. Dynapenia and Metabolic Health in Obese and Nonobese Adults Aged 70 Years and Older: The LIFE Study

6. Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes

7. Association of Accelerometry-Measured Physical Activity and Cardiovascular Events in Mobility-Limited Older Adults: The LIFE (Lifestyle Interventions and Independence for Elders) Study

8. Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

9. Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial

10. Predictors of Change in Physical Function in Older Adults in Response to Long-Term, Structured Physical Activity: The LIFE Study

11. Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial

12. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

13. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

14. Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

15. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial

16. Lessons learned from the prospective pravastatin pooling project

18. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

19. Reduction of Stroke Events With Pravastatin

20. Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events

21. Introduction

22. Isradipine in Prediabetic Hypertensive Subjects

23. Increasing utilization of dermatologists by managed care: An analysis of the National Ambulatory Medical Care Survey, 1990–1994

24. Procedures for skin diseases performed by physicians in 1993 and 1994: Analysis of data from the National Ambulatory Medical Care Survey

25. Reduction in coronary events during treatment with pravastatin

26. Effect of Cholesterol-Lowering Medications on Progression of Mild Atherosclerotic Lesions of the Carotid Arteries and on the Risk of Stroke

27. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

28. Pravastatin, lipids, and atherosclerosis in the carotid arteries: Design features of a clinical trial with carotid atherosclerosis outcome

29. Intensive glucose control and macrovascular outcomes in type 2 diabetes

30. MIDAS, The Multicenter Isradipine/Diuretic Atherosclerosis Study

31. Prognostic value of prolonged ventricular repolarization following myocardial infarction: The BHAT experience

34. Mega-trials

35. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

36. Effects of Lovastatin and Warfarin on Early Carotid Atherosclerosis

37. The Burden of Treatment Failure in Type 2 Diabetes

38. Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterol

39. Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study

40. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

41. Lessons learned from clinical trials with ultrasound end-points

42. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

43. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography

44. Pravastatin, lipids, and major coronary events

45. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study

46. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

47. The association between LDL-C and outcome: The pravastatin pooling project

48. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)

49. Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events

50. Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease

Catalog

Books, media, physical & digital resources